Neurotensin: an endogenous psychostimulant?
暂无分享,去创建一个
[1] V. Pickel,et al. High‐affinity neurotensin receptors in the rat nucleus accumbens: Subcellular targeting and relation to endogenous ligand , 2001, The Journal of comparative neurology.
[2] A. Bérod,et al. Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined , 2001, Neuroscience.
[3] K. Keefe,et al. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum , 2001, Neuroscience.
[4] D. Accili,et al. Neurotensin Gene Expression and Behavioral Responses Following Administration of Psychostimulants and Antipsychotic Drugs in Dopamine D3 Receptor Deficient Mice , 2001, Neuropsychopharmacology.
[5] T. Tzschentke. Pharmacology and behavioral pharmacology of the mesocortical dopamine system , 2001, Progress in Neurobiology.
[6] K. Fuxe,et al. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain , 2001, Neuroscience.
[7] E. Richelson,et al. Neurotensin: peptide for the next millennium , 2000, Regulatory Peptides.
[8] P. Rompré,et al. Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing , 2000, Brain Research.
[9] P. Rompré,et al. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization , 2000, Neuropharmacology.
[10] P. Kalivas,et al. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies , 2000, Psychopharmacology.
[11] Christian Broberger,et al. Neuropeptides — an overview , 2000, Neuropharmacology.
[12] P. Soubrié,et al. Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr11]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens , 2000, Neuroscience.
[13] L. Trudeau. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors , 2000, Neuroscience.
[14] Marc Laruelle,et al. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies , 2000, Brain Research Reviews.
[15] A. Beaudet,et al. Pharmacological, molecular and functional characterization of glial neurotensin receptors , 1999, Neuroscience.
[16] C. Nemeroff,et al. Does neurotensin mediate the effects of antipsychotic drugs? , 1999, Biological Psychiatry.
[17] J P Vincent,et al. Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.
[18] M. Laburthe,et al. Neurotensin and a non‐peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice , 1999, International journal of cancer.
[19] J. Krause,et al. Distinct and interactive effects of d‐amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat , 1998, The Journal of comparative neurology.
[20] W. Rostène,et al. Role of Endogenous Neurotensin in the Behavioral and Neuroendocrine Effects of Cocaine , 1998, Neuropsychopharmacology.
[21] R. Spanagel,et al. Repeated Administration of the Neurotensin Receptor Antagonist SR 48692 Differentially Regulates Mesocortical and Mesolimbic Dopaminergic Systems , 1998, Journal of neurochemistry.
[22] W. Rostène,et al. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. , 1997, Trends in pharmacological sciences.
[23] Jeffrey A Lieberman,et al. Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity , 1997, Neuropsychopharmacology.
[24] R. Christopher Pierce,et al. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.
[25] P. Rompré. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine. , 1997, European journal of pharmacology.
[26] P. Soubrié,et al. Involvement of cortical neurotensin in the regulation of rat meso‐cortico‐limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade , 1997, Synapse.
[27] W. Rostène,et al. Neurotensin and Neuroendocrine Regulation , 1997, Frontiers in Neuroendocrinology.
[28] W. Rostène,et al. Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum. , 1997, Brain research. Molecular brain research.
[29] P. Soubrié,et al. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.
[30] Anthony A. Grace,et al. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs , 1997, Trends in Neurosciences.
[31] J. S. Brog,et al. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus , 1996, Neuroscience.
[32] G. Hanson,et al. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] D. Boulay,et al. Locomotor sensitization to [d-Trp11]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats , 1996, Neuroscience Letters.
[34] T. Svensson,et al. Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat , 1995, Behavioural Brain Research.
[35] R. Roth,et al. Preexposure to, but Not Cotreatment with, the Neurotensin Antagonist SR 48692 Delays the Development of Cocaine Sensitization , 1994, Neuropsychopharmacology.
[36] M. Martres,et al. Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus Accumbens , 1994, The European journal of neuroscience.
[37] S. Gygi,et al. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions. , 1994, The Journal of pharmacology and experimental therapeutics.
[38] P. Soubrié,et al. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission , 1994, Neuroscience.
[39] P. Robledo,et al. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat , 1993, Brain Research.
[40] P. Rompré,et al. Mesencephalic microinjections of neurotensin-(1–13) and its C-terminal fragment, neurotensin-(8–13), potentiate brain stimulation reward , 1993, Brain Research.
[41] R. Roth,et al. Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex , 1992, Neuroscience Letters.
[42] Zhao-jin Wang,et al. Tyrosine hydroxylase-, neurotensin-, or cholecystokinin-containing neurons in the nucleus tractus solitarii send projection fibers to the nucleus accumbens in the rat , 1992, Brain Research.
[43] P. Rompré,et al. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13). , 1992, European journal of pharmacology.
[44] P. Duffy,et al. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[45] J. Crawley,et al. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens , 1990, Brain Research.
[46] P. Glimcher,et al. Neurotensin self-injection in the ventral tegmental area , 1987, Brain Research.
[47] C. Nemeroff,et al. Repeated neurotensin administration in the ventral tegmental area: Effects on baseline and d-amphetamine-induced locomotor activity , 1986, Neuroscience Letters.
[48] P. Kalivas,et al. Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens , 1984, Brain Research.
[49] P. Glimcher,et al. Neurotensin: A new ‘reward peptide’ , 1984, Brain Research.
[50] P. Kalivas,et al. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat , 1983, Neuroscience.
[51] P. Kalivas,et al. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. , 1982, European journal of pharmacology.
[52] C. Nemeroff,et al. Neurotensin blocks certain amphetamine-induced behaviours , 1981, Nature.
[53] K. Berridge,et al. Incentive-sensitization and addiction. , 2001, Addiction.
[54] P. Soubrié,et al. Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons. , 2000, Neuroreport.
[55] P. Soubrié,et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[56] C. Nemeroff. Neurotensin: perchance an endogenous neuroleptic? , 1980, Biological psychiatry.